Glenmark launches generic vancomycin hydrochloride injection in the US, enhancing its injectable portfolio and treatment options.
SENSEX 74,568.08
NIFTY 23,413.65
CRUDEOIL 10,358.00
+ 278.00
GOLD 158,528.00
Cenexi recovery, new product launches and capacity additions power Gland Pharma outlook
Margin revival, Semaglutide launch to drive Dr Reddy’s growth momentum in FY27
Dr. Reddy's Launches Generic Semaglutide In Canada, Expands GLP-1 Push - Dr Reddy's Laboratories (NYSE:RD
GVRP and StepsBio establish a Bengaluru CoE for advanced formulations R&D, enhancing drug delivery systems and sterile…
Cipla’s Goa facility receives VAI classification from US FDA after April inspection, indicating no regulatory or enforcement…
The merger expands the combined entity’s manufacturing, research, and development capabilities, with a focus on specialty drugs…
The recent rally in the stock followed the USFDA’s approval for Zaynich (cefepime and zidebactam), an intravenous antibiotic for…
Oval Fertility partners with Merck to enhance clinical excellence and patient experience in India's evolving IVF market.
Glenmark Pharmaceuticals' US subsidiary will pay $29.6 million to resolve antitrust and consumer protection claims over alleged…
